Document Detail

Significance and relation between magnitude of left ventricular hypertrophy and heart failure symptoms in hypertrophic cardiomyopathy.
MedLine Citation:
PMID:  15904638     Owner:  NLM     Status:  MEDLINE    
In hypertrophic cardiomyopathy (HC), an important subgroup of patients develop progressive and disabling symptoms that are related to heart failure and death. Although a direct relation has been demonstrated between left ventricular (LV) wall thickness and likelihood of sudden and unexpected death (usually in patients who are asymptomatic or mildly symptomatic), it is unresolved whether magnitude of hypertrophy is similarly associated with severity of heart failure. To determine the relation of LV wall thickness to heart failure symptoms in HC, 700 consecutive patients who had HC were assessed by 2-dimensional echocardiography. The relation between maximum level of heart failure symptoms by New York Heart Association functional class and maximum LV wall thickness was not linear but rather parabolic. Therefore, marked symptoms were most commonly associated with moderate degrees of LV hypertrophy (wall thickness 16 to 24 mm; 27%) but less frequently with extreme hypertrophy (>/=30 mm 13%) or mild hypertrophy (</=15 mm; 19%, p = 0.0001). Mean New York Heart Association functional class showed a similar pattern with respect to moderate hypertrophy (1.9 +/- 0.8), mild hypertrophy (1.6 +/- 0.9), and extreme hypertrophy (1.6 +/- 0.7, p = 0.005). Multivariable regression analysis showed the parabolic relation between heart failure symptoms and magnitude of LV hypertrophy to be independent of other hypertrophic cardiomyopathy related clinical variables. In conclusion, no direct relation was evident between symptoms of heart failure and magnitude of LV wall thickness, with implications for the natural history of HC.
Martin S Maron; Andrey G Zenovich; Susan A Casey; Mark S Link; James E Udelson; Dorothee M Aeppli; Barry J Maron
Related Documents :
16010028 - Induction and analysis of cardiac hypertrophy in transgenic animal models.
15368798 - Recent insights in the development of organ damage caused by hypertension.
18021998 - Cardiocyte nucleus shape as an indicator of heart graft aging.
9588538 - Hypertrophic cardiomyopathy in congenital myotonic dystrophy.
15390248 - Major noncardiac surgery following coronary stenting: when is it safe to operate?
19626398 - Baseline inflammation is not predictive of periprocedural troponin elevation after elec...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The American journal of cardiology     Volume:  95     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  2005 Jun 
Date Detail:
Created Date:  2005-05-20     Completed Date:  2005-07-05     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1329-33     Citation Subset:  AIM; IM    
Hypertrophic Cardiomyopathy Center, Division of Cardiology, Tufts-New England Medical Center, Boston, Massachusetts 02111, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Cardiomyopathy, Hypertrophic / complications,  physiopathology*
Child, Preschool
Heart Failure / complications,  physiopathology*
Hypertrophy, Left Ventricular / complications,  physiopathology*
Middle Aged
Regression Analysis

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Trends in mortality attributed to heart failure in Worcester, Massachusetts, 1992 to 2001.
Next Document:  Circulating levels of heart-type fatty acid-binding protein and its relation to thallium-201 perfusi...